[1] |
刘洪波,靖春颖,韩平.重组人Ⅱ型TNF受体-抗体融合蛋白联合风湿骨痛片对类风湿性关节炎患者的疗效观察[J].川北医学院学报,2019,34(4):358-361, 376.
|
[2] |
Mcinnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet, 2017, 389(186): 2328-2337.
|
[3] |
于晶晶,李慧敏,马瑞瑞,等.类风湿关节炎合并骨质疏松的发病机制和治疗进展[J].中国现代医学杂志,2020,30(24):51-56.
|
[4] |
杨二丽,李向红,丽晶,等.艾拉莫德对类风湿关节炎继发骨质疏松的治疗作用及相关机制[J/OL].广东医学,2020,41(22):2293-2297.
|
[5] |
Boström EA, Lundberg P. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation[J/OL]. PLoS One, 2013, 8(12): e81665. DOI: 10.1371/journal.pone.0081665.
|
[6] |
Clavel G, Thiolat A, Boissier MC. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38[J]. Joint Bone Spine, 2013, 80(5): 449-453.
|
[7] |
王健雄,徐胜前.类风湿关节炎与骨质疏松[J].临床内科杂志,2020,37(5):323-327.
|
[8] |
严林.炎症因子对类风湿性关节炎患者骨代谢及脂代谢的影响[J].医学临床研究,2018,35(4):716-718.
|
[9] |
Charles-Schoeman C, Meriwether D, Lee YY, et al. High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis[J]. Clin Rheumatol, 2018, 37(3): 615-622.
|
[10] |
王旭,段芳芳,董歧,等.脊柱退行性疾病需手术治疗患者的血脂及血细胞计数比值与骨密度、骨质疏松的关系[J].中国骨质疏松杂志,2020,26(11):1659-1663.
|
[11] |
中华医学会风湿病学分会.类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270.
|
[12] |
Kanis JA, Melton L3, Christiansen C, et al. The diagnosis of osteoporosis[J]. J Bone Miner Res, 1994, 9(8): 1137-1141.
|
[13] |
严伟,王中汉,刘贺.骨重建失衡导致骨质疏松发生的作用机制及其药物治疗策略[J].中国组织工程研究,2020,24(30):4866-4874.
|
[14] |
王想福,孙凤歧,叶丙霖,等.破骨细胞与骨质疏松症的关系研究进展[J].中国骨质疏松杂志,2015,21(11):1420-1424.
|
[15] |
赵蕾,陈宗涛,孙丽,等.类风湿关节炎患者骨密度与代谢关系的研究进展[J].医学综述,2020,26(24):4841-4845.
|
[16] |
冯宇翔,邵丰,汪梅姣,等.类风湿性关节炎住院患者疼痛评分骨密度与临床指标相关性研究[J].浙江临床医学,2020,22(10):1420-1421.
|
[17] |
陈可铭,徐胜前,徐月辰,等.肌少症-骨量减少/骨质疏松与类风湿关节炎患者合并脊柱骨质疏松性骨折发生的相关性研究[J].中国骨质疏松杂志,2020,26(7):1018-1022, 1082.
|
[18] |
王紫晨,马丽娜,张仲迎,等.老年人代谢综合征与骨质疏松的相关性研究[J].中华老年心脑血管病杂志,2020,22(9):904-907.
|
[19] |
张兵,刘琮,李博,等.类风湿关节炎合并骨质疏松患者骨代谢及炎症因子变化研究[J].临床和实验医学杂志,2016,15(19):1921-1923.
|
[20] |
童辉,徐胜前,龚勋,等.BMI和SMI在类风湿关节炎继发骨质疏松中的临床研究[J].中国骨质疏松杂志,2019,25(10):1463-1468.
|
[21] |
Felix J, De Munck S, Verstraete K, et al. Structure and assembly mechanism of the signaling complex mediated by human CSF-1[J]. Structure, 2015, 23(9): 1621-1631.
|
[22] |
Masteller EL, Wong BR. Targeting IL-34 in chronic inflammation[J]. Drug Discov Today, 2014, 19(8): 1212-1216.
|
[23] |
Wang Y, Bugatti M, Ulland TK, et al. Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation[J]. Eur J Immunol, 2016, 46(3): 552-559.
|
[24] |
Chang SH, Choi BY, Choi J, et al. Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis[J]. Rheumatol Int, 2015, 35(1): 71-79.
|
[25] |
Garcia S, Hartkamp LM, Malvar-Fernandez B, et al. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis[J/OL]. Arthritis Res Ther, 2016, 18(1): 75.DOI: 10.1186/s13075-016-0973-6.
|
[26] |
Yang SS, Jiang SJ, Wang Y, et al. Interleukin 34 upregulation contributes to the increment of microRNA 21 expression through STAT3 activation associated with disease activity in rheumatoid arthritis[J]. J Rheumatol, 2016,43:1312-1319.
|
[27] |
Zhou RP, Wu XS, Xie YY, et al. Functions of interleukin-34 and its emerging association with rheumatoid arthritis[J]. Immunology, 2016, 149(4): 362-373.
|
[28] |
Chemel M, Brion R, Segaliny AI, et al. Bone morphogenetic protein 2 and transforming growth factor β1 inhibit the expression of the proinflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts[J]. Am J Pathol, 2017, 187(1): 156-162.
|
[29] |
Ge Y, Huang M, Yao YM. Immunomodulation of interleukin-34 and its potential significance as a disease biomarker and therapeutic target[J]. Int J Biol Sci, 2019, 15(9): 1835-1845.
|
[30] |
曾婷婷,田永建,谭立明,等.类风湿关节炎骨质疏松危险因素分析[J].中国骨质疏松杂志,2019,25(1):74-78, 84.
|
[31] |
耿娟娟,秦福芳,张文才.NTX与2型糖尿病性骨质疏松患者血清中骨转换标志物的相关性研究[J].中国合理用药探索,2020,17(6):56-60.
|
[32] |
付涛,吴晓东,阿力·艾拜. 水飞蓟宾通过PI3K/AKT/FoxO1通路改善骨质疏松大鼠骨代谢和骨量[J].中国骨质疏松杂志,2020,26(10):1416-1420.
|
[33] |
马凤云,庞琳娜,孙聪慧.类风湿关节炎继发骨质疏松症相关影响因素的Logistic回归分析[J].中国骨质疏松杂志,2020,26(7):1009-1012.
|